Found 42 matching trials
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients NA This is a biological study for adult MDS patients who undergo HSCT procedur...
Show More Location
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
Learn More & Join Trial
Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle PHASE2 BioCart™II is a novel scaffold seeded with autologous chondrocytes to be us...
Show More Location
Tucson Orthopaedic Institute
Learn More & Join Trial
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia PHASE2 This prospective, multi-center, randomized, controlled Phase II study is to...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia PHASE2 This study is to investigate the therapeutic efficacy and side effect of ve...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Mesenchymal Stromal Cell Therapy in Renal Recipients PHASE2 This study will test the hypothesis that MSCs in combination with Everolimu...
Show More Location
Leiden University Medical Center
Learn More & Join Trial
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors PHASE2 This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Biologic Characterization of Patients With ITP NA This is a no-profit, multicenter, biological, non-pharmacologic study aimed...
Show More Location
UOC ematologia AOU di Bologna
Learn More & Join Trial
Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia PHASE2 The planned trial offers treatment cohorts for patients with full cytologic...
Show More Location
University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie
Learn More & Join Trial
Novel Approaches to Target MECOM/EVI1 in AML NA This is an academic, no-profit, multicenter, biological, non-pharmacologic ...
Show More Learn More & Join Trial
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma NA The purpose of this research is to collect health-related information as we...
Show More Location
Stephenson Cancer Center
Learn More & Join Trial